Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response prediction.

Current pharmaceutical design - 1 Jan 2012

Kennedy Sidney H, Downar Jonathan, Evans Kenneth R, Feilotter Harriet, Lam Raymond W, MacQueen Glenda M, Milev Roumen, Parikh Sagar V, Rotzinger Susan, Soares Claudio

Abstract excerpt

Identifying biological and clinical markers of treatment response in depression is an area of intense research that holds promise for increasing the efficiency and efficacy of resolving a major depressive episode and preventing future episodes. Collateral benefits include decreased healthcare cos...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Canada
Share to Decision Support Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Depression

Share to Neuroimaging

Share to Patient Selection

Share to Pattern Recognition, Automated

Share to Research Design

Source

Identifiers

PMID: 22681173
DOI: 10.2174/138161212803523635

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22681173-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response prediction.PMID 22681173Read ↗

Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures.Semantic proximity Read ↗

Advancing Depression Management Through Biomarker Discovery with a Focus on Genetic and Epigenetic Aspects: A Comprehensive Study on Neurobiological, Neuroendocrine, Metabolic, and Inflammatory PathwaysSemantic proximity Read ↗

Are there meaningful biomarkers of treatment response for depression?Semantic proximity Read ↗

Novel biomarkers in major depressionSemantic proximity Read ↗

Biomarkers predicting treatment outcome in depression: what is clinically significant?Semantic proximity Read ↗

Development and validation of a multimodal neuroimaging biomarker for electroconvulsive therapy outcome in depression: a multicenter machine learning analysisSemantic proximity Read ↗

Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder.Semantic proximity Read ↗

A review of new insights into existing major depressive disorder biomarkersSemantic proximity Read ↗

Optimizing Antidepressant Efficacy: Generalizable Multimodal Neuroimaging Biomarkers for Prediction of Treatment ResponseSemantic proximity Read ↗

The MAKE Biomarker Discovery for Enhancing anTidepressant Treatment Effect and Response Study: Design and MethodologySemantic proximity Read ↗

Applying Machine-Learning and Deep-Learning to Predict Depression from Brain MRI and Identify Depression-Related Brain BiologySemantic proximity Read ↗

Individualized Treatment Strategy for Depressive Disorder.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.